Vitamin D levels and presence of AMD are not associated

Article

Recent evidence suggesting a link between low vitamin D levels, delayed angiogenesis and reduced inflammatory response has been disproved.

Recent evidence suggesting a link between low vitamin D levels, delayed angiogenesis and reduced inflammatory response has been disproved in a study featured in Eye.

A cross-sectional clinical study led by Dr S. Golan, Department of Ophthalmology, Tel Aviv Sourasky Medical Center, Israel, looked at 1045 members of the Maccabi Healthcare Services (MHS) with age-related macular degeneration (AMD) and 8124 patients who didn't have AMD. All participants had their Vitamin D levels taken during routine examinations between 2000 and 2008. The main outcome measure was Serum 25-OH vitamin D levels.

The findings demonstrated a mean ±SD level of 25-OH vitamin D of 24.1±9.41 ng/ml for AMD patients and 24.13±9.50 ng/ml for non-AMD patients. A third of AMD patients and 32.86% of the controls had vitamin D levels of under 16 ng/ml, and the proportions of examinations in which the vitamin D level was greater than 74 ng/ml were 0.19 and 0.14%, respectively.

The results suggest the study has disproved a recent investigation into the association between reduced vitamin D levels and presence of AMD.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.